Atlas Trials

Safety and Efficacy of HB-1 for Panic Disorder

Clinical trial NCT05071430 · COMPLETED

Trial details

NCT number
NCT05071430
Sponsor
HB BioTech, LLC
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Panic Disorder
Start date
2022-02-03
Primary completion
2022-12-12
Enrollment
86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.